Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

Author： Raikou M.   McGuire A.   Colhoun H.   Betteridge D.   Durrington P.   Hitman G.   Neil H.   Livingstone S.   Charlton-Menys V.   Fuller J.  

Publisher： Springer Publishing Company

ISSN： 0012-186X

Source： Diabetologia, Vol.50, Iss.4, 2007-04, pp. : 733-740

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 12, 2015-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effective Management of the Type 2 Diabetes Patient with Cardiovascular and Renal Disease: Secondary Prevention Strategies after a Myocardial Infarction

By  

Current Diabetes Reviews, Vol. 8, Iss. 3, 2012-05 ,pp. : 219-228

Bentham Science Publishers

Access to resources Recommend Favorite

A prospective study of cardiovascular disease in patients with Type 2 diabetes - 6.3 years of follow-up

By Riu F.R.   Vert I.S.   Martin A.L.   Gonzalez R.R.   Sala A.S.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 5, 2003-09 ,pp. : 235-242

Elsevier

Access to resources Recommend Favorite

The Epidemiology of Cardiovascular Disease in Adults with Type 1 Diabetes

By  

Current Diabetes Reviews, Vol. 13, Iss. 6, 2017-10 ,pp. : 520-527

Bentham Science Publishers

Access to resources Recommend Favorite

Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case–cohort study, 1984–1998

By Thorand B.   Baumert J.   Herder C.   Meisinger C.   Koenig W.  

Diabetologia, Vol. 50, Iss. 3, 2007-03 ,pp. : 545-548

Springer Publishing Company

Access to resources Recommend Favorite